20332 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole 1,3-Diazoles Imidazole-alkanecarboxylic acids, e.g. histidine
LIGHT-ACTIVATED CATION CHANNEL AND USES THEREOF
#602Compositions for the treatment of overactive bladder
#603Methods for treating pain and hyperhidrosis
#604In vivo targeting of dendritic cells
#605COMPOSITIONS AND TREATMENTS FOR INHIBITING KINASE AND/OR HMG-COA REDUCTASE
#606Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia
#607Anti-allergic pharmaceutical composition containing at least one allergen and at least one antihistamine compound
#608METHODS OF USING ACYL HYDRAZONES AS sEH INHIBITORS
#609Novel pyrroles and imidazoles
#610Delivery and formulations of mast cell stabilizers
#611Lklf/klf2 gene expression promoter
#612Use of a mast cell activation or degranulation blocking agent in the manufacture of a medicament for the treatment of cerebral ischemia
#613Nutrition formulations and methods of providing nutrition formulations
#614Combination therapy for treating obesity or maintaining weight loss
#615Use of neurotransmitters and neuropeptides for the treatment of dry eye diseases and related conditions
#616Compositions comprising 5-alpha reductase inhibitors, and SARMs and methods of use thereof
#617Amino acid derivatives
#618Stable formulations of peptides
#619VEGF antagonist formulations
#620Compositions comprising N-propanoyl derivatives of amino acids, aminocarbohydrates and derivatives thereof
#621Transfusion preparation for peripheral intravenous administration and method of stabilizing vitamin b1
#622Methods and compositions for the treatment of parkinson's disease and other alpha-synucleinopathies
#623Stabilized liquid polypeptide formulations
#624Methods of treating ischemic related conditions
#625Radiosensitizer formulations and methods for use
#626Anti Aβ antibody formulation
#627Methods of treating factor VIIa-associated conditions with compounds having an amine nucleus
#628Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease
#629Amines, combination of amines and vanadium and amine vanadium salts for the treatment or prevention of dyslipidemia
#630Method and compounds for promoting healing and reducing inflammation
#631Amino acid composition for improving central functions
#632L-histidine in ophthalmic solutions
#633Wound care device having fluid transfer properties
#634Melanin extinguisher
#635Methods for treating Alzheimer's disease using hydroxyethylene compounds containing a heterocyclic amide bond isostere
#636Eye care kit for treating periocular disease
#637Combined use of carnosinase inhibitor with l-carnosines and composition
#638Method for scavenging radicals with urocanic acid, derivatives and analogues
#639Amino acid composition and supplementary liquid containing the same
#640Opthalmic and contact lens solutions with a peroxide source and a cationic polymeric preservative
#641Use of inhibitors of 24-hydroxylase in the treatment of cancer
#642Use of inhibitors of 24-hydroxylase in the treatment of cancer
#643Matrix metalloprotease (MMP) inhibitors and their application in cosmetic and pharmaceutical composition
#644Chewable electrolyte tablet
#645Antihistamines for increased tolerance to extreme heat
#646Methods and compositions for enhancing collagen and proteoglycan synthesis in the skin
#647Method for identifying bronchoconstriction relaxing substances
#648Composition of a transdermal delivery system, which modulates inflammation, via insitu systems, thereby promoting repair of injured, damaged or diseased joints, and soft tissue.
#649Pharmaceutical composition for intracellular acidification with cis-urocanic acid
#650Method for treating cryptorchidism
#651Formulations for non-parenteral use including hydrophobic cyclodextrins
#652Treatment of rheumatoid arthritis by inhibition of pde4
#653Neuroprotective small organic molecules, compositions and uses related thereto
#654Drugs for the treatment of neoplastic disorders
#655Methods and composition for treatment of migraine and symptoms thereof
#656Method for treating emesis with ghrelin agonists
#657Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
#658Inactive isomer compositions for use as drug-resistance-reversal agents and in prophylactic treatment
#659Spin trapping pharmaceutical compositions and methods for use thereof
#660Use of creatine analogues and creatine kinase modulators for the prevention and treatment of glucose metabolic disorders
#661Athletic patch
#662Pharmaceutical compositions containing keto-acids for endoperitoneal administration
#663Novel imidazoles
#664Method and agent for inducing apoptosis/cell death in leukemia cells
#665Methods for enhancing the transport of glucose for balancing blood sugar levels
#666Therapeutic agent for rheumatic disease comprising benzamide derivative as active ingredient
#667Methods and reagents for the treatment of immunoinflammatory disorders
#668Amidine derivatives for treating amyloidosis
#669Use of asc-1 inhibitors to treat neurological and psychiatric disorders
#670Method for identifying bronchoconstriction relaxing substances
#671Frequency assisted transdermal agent delivery method and system
#672Hemodialysis solutions and uses thereof
#673White silver-containing wound care device
#674L-ergothioneine, milk thistle, and S-adenosylmethionine for the prevention, treatment and repair of liver damage
#675Oxamide inhibitors of plasminogen activator inhibitor-1
#676Spin trapping pharmaceutical compositions and methods for use thereof
#677Compositions and methods for treating cellular proliferation disorders
#678Synergistic enhancement of cognitive ability
#679Pharmaceutical composition comprising a 5ht1 receptor agonist
#680Composition that consists of alkanedicarboxylic acids and a pharmaceutical active ingredient
#681Organ fibrosis inhibitor
#682Stable, highly pure L-cysteine compositions for injection and methods of use
#683Stable, highly pure L-cysteine compositions for injection and methods of use
#684Amino acid compositions
#685Stable, highly pure L-cysteine compositions for injection and methods of use
#686Stable, highly pure L-cysteine compositions for injection and methods of use
#687Bioactive fluid compositions
#688Stable, highly pure L-cysteine compositions for injection and methods of use
#6896-[4,4-bis(4-bromophenyl)-2,5-dioxoimidazolidin-1-yl]hexanoic acid as an antimicrobial compound
#6904-[4,4-bis(4-bromophenyl)-5-oxo-2-thioxoimidazolidin-1-yl]butanoic acid as an antimicrobial compound
#6913-(2,4,5-tris(4-chlorophenyl)-1H-imidazol-1-yl) propanoic acid as an antimicrobial compound
#692Stable, highly pure L-cysteine compositions for injection and methods of use
#693Stable, highly pure L-cysteine compositions for injection and methods of use
#694Stable, highly pure L-cysteine compositions for injection and methods of use
#695Stable, highly pure L-cysteine compositions for injection and methods of use
#696Kit and new method of treatment for skin basal cell and squamous cell carcinoma
#697Stable, highly pure l-cysteine compositions for injection and methods of use
#698Stable, highly pure L-cysteine compositions for injection and methods of use
#699Methods of treating glutathione deficiencies and deficiencies in glutathione synthetase activity
#700Amino acid compositions
#701Amino acid compositions
#702Stable, highly pure L-cysteine compositions for injection and methods of use
#703Stable, highly pure L-cysteine compositions for injection and methods of use
#704Stable, highly pure L-cysteine compositions for injection and methods of use
#705Stable, highly pure L-cysteine compositions for injection and methods of use
#706Stable, highly pure L-cysteine compositions for injection and methods of use
#707Topical transdermal method for delivering nutrients through the skin for expedited wound healing and skin rejuvenation
#708Method for increasing muscle strength
#709Method of safely administering nitrate dietary supplements and compositions
#710Therapeutic compositions comprising imidazole and imidazolium compounds
#711Compositions and methods of improving cognitive performance
#712Therapeutic compositions comprising imidazole and imidazolium compounds
#713Amino acid compositions
#714Topical transdermal method for delivering nutrients through the skin for expedited wound healing and skin rejuvination